Tocilizumab inhibits neuronal cell apoptosis and activates STAT3 in cerebral infarction rat model
Cerebral infarction is a severe hypoxic ischemic necrosis with accelerated neuronal cell apoptosis in the brain. As a monoclonal antibody against interleukin 6, tocilizumab (TCZ) is widely used in immune diseases, whose function in cerebral infarction has not been studied. This study aims to reveal...
Main Authors: | Shaojun Wang, Jun Zhou, Weijie Kang, Zhaoni Dong, Hezuo Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2016-01-01
|
Series: | Bosnian Journal of Basic Medical Sciences |
Subjects: | |
Online Access: | https://bjbms.org/ojs/index.php/bjbms/article/view/853 |
Similar Items
-
A new bioassay for measuring the strength of IL-6/STAT3 signal inhibition by tocilizumab in patients with rheumatoid arthritis
by: Shuntaro Saito, et al.
Published: (2017-10-01) -
Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-of-function mutation
by: Wenjie Wang, et al.
Published: (2021-03-01) -
Inhibition of MicroRNA-124 Reduces Cardiomyocyte Apoptosis Following Myocardial Infarction via Targeting STAT3
by: Fang He, et al.
Published: (2018-11-01) -
PROSPECTS FOR USING TOCILIZUMAB IN SYSTEMIC SCLEROSIS
by: L. P. Ananyeva
Published: (2016-02-01) -
Targeting the IL-6/STAT3 Signalling Cascade to Reverse Tamoxifen Resistance in Estrogen Receptor Positive Breast Cancer
by: Ho Tsoi, et al.
Published: (2021-03-01)